Drug profile · INN
pramlintide acetate
SYMLIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pramlintide acetate (SYMLIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN pramlintide acetate
Brand SYMLIN
Route SUBCUTANEOUS
Formulation INJECTABLE
Frequently asked questions
What is pramlintide acetate?
pramlintide acetate (SYMLIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for pramlintide acetate?
SYMLIN is a marketed brand name for pramlintide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pramlintide acetate?
pramlintide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.